Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

CYTKCYTK
Showing 8 of 31 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in CYTOKINETICS INC

RHUMBLINE ADVISERS holds 421,799 shares of CYTK (CYTOKINETICS INC), worth $35.9M as of 2026-Q2. The position was increased (+14.1% shares). CYTK represents 0.0% of RHUMBLINE ADVISERS's portfolio.

Current Value

$35.9M

Current Shares

421,799

Total Value Change

+$15.9M

Total Shares Change

+43,123

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
421,799
+14.1%
$35.9M0.0%$85.19
33
2026-Q1
Increased
369,575
+3.5%
$24.4M0.0%$60.72
30
2025-Q4
Decreased
356,995
-7.5%
$22.7M0.0%$61.37
0
2025-Q3
Decreased
385,813
-1.1%
$21.2M0.0%$53.89
0
2025-Q2
Increased
389,940
+4.3%
$12.9M0.0%$33.16
29
2025-Q1
Decreased
373,855
-2.6%
$15M0.0%$43.19
0
2024-Q4
Increased
383,883
+1.4%
$18.1M0.0%$47.15
29
2024-Q3
Decreased
378,676
-0.1%
$20M0.0%$52.34
0

Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used